DOHA: Sidra Medicine, a member of Qatar Foundation, was awarded the prestigious 'Samir Abbas Best Research Award' at the 31st Annual Scientific Meeting of the Middle East Fertility Society (MEFS), for its contribution to advancing fertility research.
The award was presented in recognition of a pioneering study that sheds light on the complexities of recurrent implantation failure (RIF), conducted by a Qatar lead team and co-authored by a Qatari clinical embryologist Dr Abdulla Almohammadi.
Titled 'The reproductive potential of vitrified-warmed euploid embryos declines following repeated uterine transfers', the study, a collaborative effort with Hamad Medical Corporation, was published earlier this year in Reproductive Biology and Endocrinology.
Dr Abdulla Almohammadi, said, "Our findings highlight the intricate nature of RIF, which can be a frustrating and challenging burden on couples, both emotionally and financially. While preimplantation genetic testing for aneuploidy (PGT-A) addresses many cases, some remain unresolved."
He explained that the research will also enable clinicians to tailor treatment strategies, including addressing underlying embryonic and uterine factors, that can improve outcomes and patient well-being.
He added that receiving the Samir Abbas Best Research Award at MEFS 2024, further validates the far-reaching aspects of our study in "being able to transform lives." The findings of the study will also provide valuable insights to enhance patient counseling and management strategies for individuals facing RIF, including the potential to improve overall success rates and patient experiences in fertility treatments.
The three-day MEFS Conference, held in Doha, brought together more than 1,200 professionals from the fertility care community across the region and served as a key platform to showcase advances in fertility care, fostering collaboration between physicians, embryologists, nurses and researchers.
